Journal of Clinical Medicine

Journal Browser

► Journal Browser

Moving Forward to New Trends in Pulmonary Diseases: 2nd Edition

Share This Special Issue

Editors

Special Issue Information

Dear Colleagues,

It is my pleasure to invite you to contribute to this Special Issue, “Moving Forward to New Trends in Pulmonary Diseases: 2nd Edition”. Following the success of our first edition, in which we published 9 papers, we are launching this new edition to further explore this field. For more details, please visit https://www.mdpi.com/journal/jcm/special_issues/41E5JFZLDQ.

This Special Issue aims to showcase cutting-edge research and emerging trends in the diagnosis, treatment, and management of various pulmonary diseases, including tuberculosis, chronic obstructive pulmonary disease, interstitial lung disease, bronchiectasis, lung cancer, and sleep apnea. Despite recent advances, many challenges persist, such as early detection, drug resistance, and optimizing individualized treatment strategies. Tuberculosis, in particular, remains a global public health priority, with drug-resistant strains posing significant diagnostic and therapeutic hurdles. To address these core problems, we welcome submissions that explore novel diagnostic methods, multidisciplinary therapeutic approaches, and innovative rehabilitation techniques tailored to meet patient-specific needs. This Special Issue aims to mobilize collaborative efforts that foster a deeper understanding of pulmonary pathophysiology, thereby paving the way for improved patient outcomes and more effective, personalized care strategies in respiratory medicine.

Dr. Ramona Cioboata
Prof. Dr. Costin Teodor Streba
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Benefits of Publishing in a Special Issue

Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.

Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.

Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.

External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.

Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Related Special Issue

Published Papers (1 paper)

Order results

Result details

Show export options Show export options

Select all

Export citation of selected articles as:

Research

17 pages, 1108 KB

Open AccessArticle

Pulmonary Telerehabilitation and Telemonitoring for Patients with Chronic Obstructive Pulmonary Disease: A Single-Arm Pilot Feasibility Study

by Matías Otto-Yáñez, Rodrigo Torres-Castro, Lea Soliman, Onah Chiemelie, Sandra C. Webber, Renata Mancopes, Antonio Sarmento and Diana C. Sanchez-Ramirez

J. Clin. Med. 2026, 15(13), 5292; https://doi.org/10.3390/jcm15135292 - 7 Jul 2026

Abstract

Background: Pulmonary rehabilitation is effective for people with chronic obstructive pulmonary disease (COPD), but access remains limited. Telerehabilitation with telemonitoring may improve access to home-based care; however, feasibility data are currently scarce. This study assessed the feasibility, acceptability, and occurrence of adverse effects in a videoconference-based pulmonary telerehabilitation program supported by wearable devices in individuals with COPD. Methods: Our one-group pre-post feasibility study evaluated an 8-week intervention comprising two supervised exercise sessions and one education session per week. Telemonitoring included wearable-device data capture (heart rate, peripheral oxygen saturation, step count) and symptom severity reporting. Feasibility outcomes included recruitment rate, study completion, dropout rate, session attendance, data-submission compliance, adverse events, and participant satisfaction. Exploratory clinical outcomes were assessed pre- and post-intervention. Results: Of 32 eligible individuals, 15 consented and attended baseline assessment (recruitment rate: 47%), and nine completed the study (completion: 60%; dropout: 40%). Among completers, median age was 67 years (interquartile range [IQR] 62–73), and seven (78%) were women. Mean session attendance was 94 ± 6.6%. Data submission rates averaged 86 ± 7.7% for the O2 ring and 97 ± 6.4% for symptom severity reporting, while smartwatch data were submitted by all participants (100%). No adverse events were reported, and participant satisfaction was high. No statistically significant pre-post changes were observed in clinical outcomes. Mean 6-min walk test distance increased by 29 m, a potentially clinically relevant but exploratory finding. Conclusions: A videoconference-based pulmonary telerehabilitation program supported by wearable devices appears to be operationally deliverable among participants who remained engaged, with no adverse events observed in this small, selected group of participants with COPD. Findings should be interpreted cautiously due to the small sample size, one-group design, and attrition. Full article

(This article belongs to the Special Issue Moving Forward to New Trends in Pulmonary Diseases: 2nd Edition)

► Show Figures

Journal Menu

Journal Browser

Moving Forward to New Trends in Pulmonary Diseases: 2nd Edition

Share This Special Issue

Editors

Special Issue Information

Keywords

Benefits of Publishing in a Special Issue

Related Special Issue

Published Papers (1 paper)

Research

Further Information

Guidelines

MDPI Initiatives

Follow MDPI